This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Celldex Therapeutics Inc
CLDX : NASDAQ : Health Care
$14.54 0.35 | 2.47%
Today's Range: 14.21 - 14.63
Avg. Daily Volume: 1,910,800
09/17/14 - 11:16 AM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CLDX CELLDEX THERAPEUTICS INC 14.23 1272.22 n/m 2.61 -71.87
IRWD IRONWOOD PHARMACEUTICALS INC 12.59 1521.70 n/m 31.41 -76.96
CLVS CLOVIS ONCOLOGY INC 44.25 1502.91 n/m 13.63 n/a
AGIO AGIOS PHARMACEUTICALS 43.40 1495.48 n/m 29.83 375.97
DYAX DYAX CORP 10.26 1397.46 n/m 64.25 22.36
CBPO CHINA BIOLOGIC PRODUCTS INC 54.28 1328.83 23.30 212.09 8.91
KERX KERYX BIOPHARMACEUTICALS INC 13.84 1270.79 n/m 10.00 42.85
ACOR ACORDA THERAPEUTICS INC 29.67 1238.57 64.50 355.16 11.74
PTLA PORTOLA PHARMACEUTICALS INC 27.55 1140.49 n/m 9.61 269.39
HALO HALOZYME THERAPEUTICS INC 8.99 1126.50 n/m 58.86 10.20
PTCT PTC THERAPEUTICS INC 36.48 1096.95 n/m 31.59 360.95
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CLDX Ind Avg S&P 500
n/m 81.35 19.67

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs